. 2018 Jul 13;29(10):2574–2582. doi: 10.1681/ASN.2017111204

Table 2.

Adjusted hazard ratios for transplantation, mortality and delisting in VA patients compared to other insurance groups nationally

Insurance Group	All Transplants	Deceased Donor Transplant	Living Donor Transplant	Death	Delisting^a
VA versus private	0.72 (0.68, 0.76)^b	0.85 (0.80, 0.90)^b	0.51 (0.46, 0.57)^b	0.89 (0.82, 0.97)^b	1.38 (1.26, 1.51)^b
VA versus Medicare	0.85 (0.81, 0.90)^b	0.91 (0.85, 0.96)^b	0.77 (0.69, 0.86)^b	0.77 (0.71, 0.84)^b	1.10 (1.001, 1.20)^b
VA versus Medicaid	1.00 (0.94, 1.06)	1.01 (0.95, 1.08)	1.00 (0.89, 1.12)	0.76 (0.70, 0.83)^b	1.04 (0.95, 1.15)

Models adjusted for age group, race, sex, diagnosis group, time on dialysis at listing, candidate status at listing, panel reactive antibody, body mass index group, education, malignancy, peripheral vascular disease, region, year of listing, log distance to center, and community risk score. Model of deceased donor transplant excludes live donor transplants. Model of living donor transplant excludes deceased donor transplants.

Delisting for reasons of “health deterioration” or “other.”

P<0.05